Neurotechnology for Pain

被引:5
|
作者
Fisher, Lee E. [1 ,2 ,3 ]
Lempka, Scott F. [4 ,5 ]
机构
[1] Univ Pittsburgh, Dept Phys Med & Rehabil, Rehab Neural Engn Labs, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA
[3] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA
[4] Univ Michigan, Dept Biomed Engn, Biointerfaces Inst, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA
关键词
chronic pain; deep brain stimulation; pain management; peripheral nervous system; spinal cord stimulation; transcutaneous electric nerve stimulation; SPINAL-CORD STIMULATION; DEEP BRAIN-STIMULATION; MOTOR CORTEX STIMULATION; DORSAL-ROOT GANGLION; CHRONIC NEUROPATHIC PAIN; LOW-BACK-PAIN; KILOHERTZ-FREQUENCY; NERVE-STIMULATION; CONDUCTION BLOCK; INTRACTABLE PAIN;
D O I
10.1146/annurev-bioeng-111022-121637
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Neurotechnologies for treating pain rely on electrical stimulation of the central or peripheral nervous system to disrupt or block pain signaling and have been commercialized to treat a variety of pain conditions. While their adoption is accelerating, neurotechnologies are still frequently viewed as a last resort, after many other treatment options have been explored.We review the pain conditions commonly treated with electrical stimulation, as well as the specific neurotechnologies used for treating those conditions. We identify barriers to adoption, including a limited understanding of mechanisms of action, inconsistent efficacy across patients, and challenges related to selectivity of stimulation and off-target side effects. We describe design improvements that have recently been implemented, as well as some cutting-edge technologies that may address the limitations of existing neurotechnologies. Addressing these challenges will accelerate adoption and change neurotechnologies from last-line to first-line treatments for people living with chronic pain.
引用
收藏
页码:387 / 412
页数:26
相关论文
共 50 条
  • [1] AI and Neurotechnology
    Berger S.
    Rossi F.
    Communications of the ACM, 2023, 66 (03) : 58 - 68
  • [2] The ethics of neurotechnology
    Irene Jarchum
    Nature Biotechnology, 2019, 37 : 993 - 996
  • [3] The promise of neurotechnology
    Schwartz, Andrew
    SCIENCE, 2015, 350 (6256) : 11 - 11
  • [4] The ethics of neurotechnology
    Jarchum, Irene
    Chang, Edward F.
    Etkin, Amit
    Gallant, Jack L.
    Greely, Henry T.
    Illes, Judy
    NATURE BIOTECHNOLOGY, 2019, 37 (09) : 993 - 996
  • [5] Pain Assessment: Subjectivity, Objectivity, and the Use of Neurotechnology Part One: Practical and Ethical Issues
    Giordano, James
    Abramson, Kim
    Boswell, Mark V.
    PAIN PHYSICIAN, 2010, 13 (04) : 305 - 315
  • [6] An Ethics Toolbox for Neurotechnology
    Farah, Martha J.
    NEURON, 2015, 86 (01) : 34 - 37
  • [7] Neurotechnology for intelligence analysts
    Kruse, Amy A.
    Boyd, Karen C.
    Schulman, Joshua J.
    CHEMICAL AND BIOLOGICAL SENSING VII, 2006, 6218
  • [8] Soft robotics neurotechnology
    Sadra Bakhshandeh
    Nature Reviews Bioengineering, 2023, 1 (6): : 389 - 389
  • [9] Neurotechnology of stereoscopic vision
    Krasil'nikov, N. N.
    Krasil'nikova, O., I
    JOURNAL OF OPTICAL TECHNOLOGY, 2018, 85 (08) : 511 - 514
  • [10] Neurotechnology: Summa technologiae
    Denk, Winfried
    Miesenboeck, Gero
    CURRENT OPINION IN NEUROBIOLOGY, 2012, 22 (01) : 1 - 2